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Background
Diffuse myocardial fibrosis can be assessed by cardiac
magnetic resonance (CMR) using the myocardial longitu-
dinal relaxation time constant (T1). Mitral valve prolapse
(MVP) is a common valvulopathy with known arrhythmic
complications and in-vitro evidence of overexpression of
pro-fibrotic TGF-beta. Papillary muscle fibrosis has been
described in MVP, but the potential association of MVP
with diffuse myocardial fibrosis is unknown. This associa-
tion is important as it may increase our future understand-
ing of ventricular arrhythmias in MVP.
Methods
A retrospective analysis was performed on images of 41
consecutive MVP patients referred for CMR between
2006-2011. Age and gender matched controls (n = 31) free
of significant cardiac disease based on clinical and CMR
findings were also identified. Arrhythmia analysis was
available in a subset of patients. Complex ventricular
arrhythmia (ComVA) was defined as Grade III or higher
by the Lown and Wolf classification on Holter or event
monitor. CMR images were acquired using a Philips
Achieva 1.5 T CMR scanner. Left ventricular (LV) septal
T1 times were derived from Look-Locker sequences after
administration of 0.2 mmol/kg gadopentetate dimeglu-
mine. Late gadolinium enhancement (LGE) CMR images
were available for all subjects. Velocity encoded CMR was
used to quantify mitral regurgitation (MR) fraction (MRF).
Results
MVP patients had significantly shorter post-contrast T1
times when compared to controls (334 ± 52 vs. 363 ±
58 ms; p = 0.03) (Figure) despite similar LV ejection
fraction (61 ± 3 vs 60 ± 6 %, p = 0.84). MVP patients
had greater LV end-diastolic volume and MRF com-
pared to controls (136 ± 4.2 vs 84 ± 17 ml/m2, and 21 ±
24 vs 0%, both p < 0.05). There was no significant dif-
ference in post-contrast T1 times between MVP subjects
with ≤ mild MR (MRF 0-15%) and > mild MR (RF >
16%) (347 vs. 334 ms; p = 0.59). Among MVP patients
with available arrhythmia data (n = 19), those with
ComVA (n=12) had even shorter post-contrast T1 time
when compared to controls (322 ± 42 vs. 363 ± 58 ms;
p = 0.016). In the MVP ComVA subgroup, the majority
(11/12 or 91%) had T1 times ≤ 350 ms, but only 5/12
or 41% had papillary muscle LGE, p = 0.009.
Conclusions
MVP is associated with reduced post-contrast T1 times
despite preserved LV systolic function, suggestive of
subclinical diffuse myocardial fibrosis. Mitral regurgita-
tion alone is less likely to be the primary contributor to
diffuse LV interstitial derangement in MVP. Complex
ventricular arrhythmia is observed in MVP patients with
diffuse myocardial fibrosis even in the absence of papil-
lary muscle LGE. Further studies are needed to clarify if
ventricular arrhythmias in MVP are secondary to diffuse
rather than localized fibrosis.
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Figure 1 Post-contrast myocardial T1 time in mitral valve prolapse
patients and in the control group.
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